Delivering A Patient-Centric Approach to Recruitment and Retention for Clinical Trials
SOUTHBOROUGH, MA – December 7, 2020 –Veristat, a global clinical research organization, was named among the Top Patient Recruitment Companies of 2020 by Pharma Tech Outlook.
Delivering on Customer Demand for Pharmacovigilance
from Clinical Trial Conduct to Post-Marketing Support
SOUTHBOROUGH, MA – October 22, 2020 – Cell and gene therapies represent the next great wave of therapeutic innovation and have led to the development of promising therapies worldwide.
Veristat Enhances Patient-Centricity Offering by Delivering Clinical Trials
Directly to Patients
SOUTHBOROUGH, MA – September 30, 2020 – Veristat, a scientific-minded global clinical research organization (CRO), announced today the launch of a virtual clinical trial solution that is flexible and customizable so that patient interactions can be conducted at the clinical site, remotely at-home, or through a hybrid combination of both strategies.
Increasing Its Footprint and Expanding Therapeutic Expertise to Guide Sponsors Throughout the Clinical Development Lifecycle
Expanding Its Team of Regulatory Experts to Guide Biopharmaceutical Sponsors
Along the Pathway to Market Approval
Veristat Expands Operations into Taiwan to Support Growing Client Demand for Clinical Trial, Biostatistics and Programming Excellence in the Region
Opens office in Taipei, Taiwan
Veristat Celebrates Its Support of over 75 Global Regulatory Submissions Since Its Founding
Veristat Partners with TRI to Provide Centralized and Risk-Based Monitoring Technology to Their Biopharmaceutical Clients